bioAffinity Technologies (BIAF) EBIT Margin (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly EBIT Margin of 267.62% for Q1 2026, down 12589.0% YoY from N/an in Q1 2025, and down 35.89% sequentially from 196.94% in Q4 2025.
bioAffinity Technologies (BIAF) EBIT Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed EBIT Margin across 5 years of filings, most recently posting 267.62% for Q1 2026.
- In Q1 2026, EBIT Margin fell 12589.0% year-over-year to 267.62%; the TTM figure through Mar 2026 stood at 204.29% (down 9491.0% YoY), while the FY2025 annual figure was 171.58%, down 7594.0% from the prior year.
- EBIT Margin fell to 267.62% in Q1 2026, from 196.94% in the prior quarter.
- Over the last five years, EBIT Margin for BIAF reached as high as 80.84% in Q1 2024 and fell as low as 169160.69% in Q1 2023.
- The 5-year median for EBIT Margin is 197.55% (2025), against an average of 24179.53%.
- Annual changes were most pronounced in 2024 — EBIT Margin soared 16907986 bps — and 2026, when it plunged 12589 bps.
- A 5-year view of EBIT Margin shows it stood at 69213.17% in 2022, then soared by 100 bps to 105.83% in 2023, then slipped by 26 bps to 133.47% in 2024, then slumped by 48 bps to 196.94% in 2025, then slumped by 36 bps to 267.62% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 267.62%, 196.94%, and 158.56% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 31.78% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -13.42% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.74% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 25.23% |
| 10 | bioAffinity Technologies | 3.78 Mn | 675,591.56 | - | -267.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -267.62% |
| Dec 31, 2025 | -196.94% |
| Sep 30, 2025 | -158.56% |
| Jun 30, 2025 | -198.16% |
| Mar 31, 2025 | -141.73% |
| Dec 31, 2024 | -133.47% |
| Sep 30, 2024 | -83.98% |
| Jun 30, 2024 | -87.08% |
| Mar 31, 2024 | -80.84% |
| Dec 31, 2023 | -105.83% |
| Sep 30, 2023 | -768.72% |
| Jun 30, 2023 | -9,009.78% |
| Mar 31, 2023 | -169,160.69% |
| Dec 31, 2022 | -69,213.17% |
| Sep 30, 2022 | -84,883.13% |
| Jun 30, 2022 | -52,382.77% |